Stroke (CVA) or TIA Clinical Trials

9 recruitingLast updated: June 18, 2026

There are 9 actively recruiting stroke (cva) or tia clinical trials across 8 countries. Studies span Not Applicable, Phase 2. Top locations include Arnhem, Gelderland, Netherlands, Barcelona, Spain, Chūō, Yamanashi, Japan. Updated daily from ClinicalTrials.gov.


Stroke (CVA) or TIA Trials at a Glance

9 actively recruiting trials for stroke (cva) or tia are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Arnhem, Barcelona, and Chūō. Lead sponsors running stroke (cva) or tia studies include Centre Hospitalier Universitaire de Nice, Chinese University of Hong Kong, and Baylor Research Institute.

Browse stroke (cva) or tia trials by phase

About Stroke (CVA) or TIA Clinical Trials

Looking for clinical trials for Stroke (CVA) or TIA? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Stroke (CVA) or TIA trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Stroke (CVA) or TIA clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Pemafibrate for Symptomatic ICAS RCT

HypertriglyceridaemiaStroke (CVA) or TIAIntracranial Atherosclerotic Disease (ICAD)
Tokyo Women's Medical University270 enrolled19 locationsNCT07562178
Recruiting
Not Applicable

Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

Stroke, IschemicStrokeStroke (CVA) or TIA+7 more
Maastricht University Medical Center613 enrolled10 locationsNCT07556887
Recruiting
Not Applicable

NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks

Stroke RecurrenceStroke (CVA) or TIA
Hospital Universitari Vall d'Hebron Research Institute250 enrolled1 locationNCT07500116
Recruiting
Not Applicable

Early Functional Proprioceptive Stimulation Post-stroke

Stroke (CVA) or TIA
Centre Hospitalier Universitaire de Nice32 enrolled1 locationNCT06192953
Recruiting
Not Applicable

Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)

StrokeStroke, AcuteStroke (CVA) or TIA+2 more
Baylor Research Institute94 enrolled1 locationNCT06569121
Recruiting
Phase 2

[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease

Atherosclerosis Cardiovascular DiseaseStroke (CVA) or TIACarotid Artery Plaque+1 more
Universitaire Ziekenhuizen KU Leuven24 enrolled1 locationNCT07104487
Recruiting

Characterising the Neuromuscular Function of Post Stroke Patients

Stroke (CVA) or TIA
University of Nottingham16 enrolled1 locationNCT07013188
Recruiting
Not Applicable

Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial With a Historical Control Group

Brain DiseasesStroke, IschemicStroke+5 more
Chinese University of Hong Kong100 enrolled1 locationNCT06728592
Recruiting

The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)

Cognitive ImpairmentStrokeCerebrovascular Disorders+3 more
Imperial College London700 enrolled1 locationNCT05885295